Results 161 to 170 of about 7,011 (197)
Some of the next articles are maybe not open access.

Related searches:

Acitretin

Reactions Weekly, 2017
Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory disease of the pilosebaceous follicle that severely affects patients' quality of life and can be challenging for clinicians to manage. A few case series have reported on the efficacy of acitretin monotherapy in the treatment of intractable HS.To assess the efficacy of acitretin for the ...
Marcus G, Tan   +3 more
  +10 more sources

Acitretin

Dermatologic Therapy, 2013
Rajiv I Nijhawan
exaly   +3 more sources

Acitretin embryopathy: A case report [PDF]

open access: yesBirth Defects Research Part A: Clinical and Molecular Teratology, 2004
Fil: Barbero, Pablo. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica; Argentina.Fil: Lotersztein, Vanesa. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica; Argentina.Fil: Bronberg, Ruben. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética
Pablo Barbero
exaly   +2 more sources

Acitretin revisited in the era of biologics

open access: yesJournal of Dermatological Treatment, 2011
Item does not contain fulltextAcitretin is a time-honored treatment for psoriasis. During the last decade biologics have revolutionized the treatment of psoriasis.
Booij, M.T., Kerkhof, P.C. van de
exaly   +2 more sources

Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study

open access: yesDermatologic Therapy, 2016
Acitretin has been used off-label for years to treat chronic hand eczema, but acitretin is less often prescribed as alitretinoine was approved. This study evaluates both retinoids in a daily practice cohort of patients with severe chronic hand eczema in ...
Klaziena Politiek   +2 more
exaly   +2 more sources

Optimizing acitretin use in patients with plaque psoriasis

open access: yesDermatologic Therapy, 2017
Acitretin is one of the systemic agents used for the treatment of psoriasis. Because different acitretin dosages resulted therapeutically successful, there is no general agreement on the optimal dose regimen.
Andrea Chiricozzi   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy